PAPA Medical Inc.
PAPA
NASDAQ
Recommendation
Prev Close
--
Volume
--
Avg Vol (90D)
--
Market Cap
--
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 46.97M | 37.72M | 37.00M | 33.78M | 30.96M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 46.97M | 37.72M | 37.00M | 33.78M | 30.96M |
| Cost of Revenue | 35.83M | 28.40M | 27.82M | 25.37M | 22.85M |
| Gross Profit | 11.14M | 9.31M | 9.18M | 8.41M | 8.11M |
| SG&A Expenses | 8.88M | 7.65M | 6.75M | 5.98M | 5.15M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 45.63M | 36.83M | 35.23M | 31.92M | 28.48M |
| Operating Income | 1.34M | 886.00K | 1.77M | 1.86M | 2.47M |
| Income Before Tax | 1.31M | 792.00K | 1.83M | 1.97M | 2.58M |
| Income Tax Expenses | 150.60K | 106.00K | 612.20K | 646.40K | 841.30K |
| Earnings from Continuing Operations | 1.16 | 0.69 | 1.22 | 1.32 | 1.74 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.16M | 686.00K | 1.22M | 1.32M | 1.74M |
| EBIT | 1.34M | 886.00K | 1.77M | 1.86M | 2.47M |
| EBITDA | 1.99M | 1.41M | 1.97M | 2.03M | 2.62M |
| EPS Basic | 0.06 | 0.03 | 0.06 | 0.07 | 0.09 |
| Normalized Basic EPS | 0.04 | 0.03 | 0.06 | 0.06 | 0.08 |
| EPS Diluted | 0.06 | 0.03 | 0.06 | 0.07 | 0.09 |
| Normalized Diluted EPS | 0.04 | 0.03 | 0.06 | 0.06 | 0.08 |
| Average Basic Shares Outstanding | 80.00M | 80.00M | 80.00M | 80.00M | 80.00M |
| Average Diluted Shares Outstanding | 80.00M | 80.00M | 80.00M | 80.00M | 80.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |